Evidence map›Paper›PMID 35492705›Full record

ArticleFrontiers in psychiatry2022

Social Communication of Maternal Immune Activation-Affected Offspring Is Improved by Si-Based Hydrogen-Producing Agent.

Noriyoshi Usui, Kazumasa Matsumoto-Miyai, Yoshihisa Koyama, Yuki Kobayashi, Yukiko Nakamura, Hikaru Kobayashi, Shoichi Shimada

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Noriyoshi UsuiDepartment of Neuroscience and Cell Biology, Graduate School of Medicine, Osaka University, Suita, Japan.
Kazumasa Matsumoto-MiyaiGraduate School of Comprehensive Rehabilitation, Osaka Prefecture University, Osaka, Japan.
Yoshihisa KoyamaDepartment of Neuroscience and Cell Biology, Graduate School of Medicine, Osaka University, Suita, Japan.
Yuki KobayashiInstitute of Scientific and Industrial Research, Osaka University, Suita, Japan.
Yukiko NakamuraDepartment of Neuroscience and Cell Biology, Graduate School of Medicine, Osaka University, Suita, Japan.
Hikaru KobayashiInstitute of Scientific and Industrial Research, Osaka University, Suita, Japan.
Shoichi ShimadaDepartment of Neuroscience and Cell Biology, Graduate School of Medicine, Osaka University, Suita, Japan.
Osaka University · JPOsaka Prefecture University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maternal immune activation (MIA) is triggered by infection or autoimmune predisposition during pregnancy, and cytokines produced by MIA are transmitted through the placenta to the fetal brain, implicating at the onset risks and vulnerability for developmental and psychiatric disorders, such as autism spectrum disorder (ASD) and schizophrenia. To address these kinds of problem in child health, we have developed a silicon (Si)-based hydrogen-producing antioxidant (Si-based agent) that continuously and effectively produces hydrogen in the body. Medical hydrogen is known to have antioxidative, anti-inflammatory, and antiapoptotic effects, therefore we applied our Si-based agent as a potential therapeutic agent to MIA. Using a MIA mouse model, we found that the Si-based agent improved the social communication of MIA offspring mice. We also found that the Si-based agent suppressed the expressions of inflammation-associated genes

Indexed as

autism spectrum disorder (ASD)hydrogeninflammationmaternal immune activation (MIA)neurodevelopmental disorders (NDDs)siliconsocial communicationultrasonic vocalization (USV)

Identifiers

PMID35492705
PMCPMC9043691
OpenAlexW4224135191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.